275
Participants
Start Date
December 31, 1997
Primary Completion Date
September 30, 2003
Study Completion Date
September 30, 2003
epoetin alfa
quality-of-life assessment
Memorial Sloan-Kettering Cancer Center, New York
George Washington University Medical Center, Washington D.C.
Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore
Duke Comprehensive Cancer Center, Durham
Cleveland Clinic Taussig Cancer Center, Cleveland
Rush Cancer Institute, Chicago
Comprehensive Cancer Centers of the Desert, Palm Springs
Division of Oncology, Palo Alto
Alta Bates Comprehensive Cancer Center, Berkeley
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles
H. Lee Moffitt Cancer Center and Research Institute, Tampa
University of Chicago Cancer Research Center, Chicago
Beth Israel Deaconess Medical Center, Boston
Roswell Park Cancer Institute, Buffalo
Milton S. Hershey Medical Center, Hershey
Vanderbilt-Ingram Cancer Center, Nashville
University of Texas - MD Anderson Cancer Center, Houston
National Cancer Institute (NCI)
NIH
Memorial Sloan Kettering Cancer Center
OTHER